Deferred Tax Assets, Valuation Allowance of HeartSciences Inc. from 30 Apr 2022 to 31 Jul 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: HeartSciences Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Apr 2022 to 31 Jul 2025.
HeartSciences Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Jul 2025 was $15,461,664, a 14% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

HeartSciences Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$15,461,664	+$1,852,726	+14%	31 Jul 2025	10-Q	11 Sep 2025	2025	Q1
Q1 2025	$15,030,694	+$1,850,412	+14%	30 Apr 2025	10-Q	11 Sep 2025	2025	Q1
Q4 2024	$14,592,186	+$1,815,631	+14%	31 Jan 2025	10-Q	13 Mar 2025	2025	Q3
Q3 2024	$14,062,146	+$1,680,530	+14%	31 Oct 2024	10-Q	16 Dec 2024	2025	Q2
Q2 2024	$13,608,938	+$1,591,900	+13%	31 Jul 2024	10-Q	12 Sep 2024	2025	Q1
Q1 2024	$13,180,282	+$1,730,987	+15%	30 Apr 2024	10-K	24 Jul 2025	2025	FY
Q4 2023	$12,776,555	+$1,652,848	+15%	31 Jan 2024	10-Q	14 Mar 2024	2024	Q3
Q3 2023	$12,381,616	+$1,613,588	+15%	31 Oct 2023	10-Q	14 Dec 2023	2024	Q2
Q2 2023	$12,017,038	+$1,594,602	+15%	31 Jul 2023	10-Q	14 Sep 2023	2024	Q1
Q1 2023	$11,449,295	+$1,327,290	+13%	30 Apr 2023	10-K	29 Jul 2024	2024	FY
Q4 2022	$11,123,707			31 Jan 2023	10-Q	16 Mar 2023	2023	Q3
Q3 2022	$10,768,028			31 Oct 2022	10-Q	15 Dec 2022	2023	Q2
Q2 2022	$10,422,436			31 Jul 2022	10-Q	12 Sep 2022	2023	Q1
Q1 2022	$10,122,005			30 Apr 2022	10-K	19 Jul 2023	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.